NSLI
CME icon

Nan Shan Life Insurance’s CME Group CME Stock Holding History

Nan Shan Life Insurance’s Portfolio CME Stock Details CME Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$44.2M Buy
200,237
+97,697
+95% +$27M 1.39% 26
2026
Q1 		$30.3M Buy
+102,540
New +$30.5M 1.1% 32
2025
Q4 		– Sell
-164,720
Closed -$44.5M – 87
2025
Q3 		$44.5M Buy
164,720
+15,710
+11% +$4.27M 0.95% 31
2025
Q2 		$41.1M Buy
149,010
+120,454
+422% +$32.8M 0.91% 34
2025
Q1 		$7.58M Sell
28,556
-25,344
-47% -$6.25M 0.18% 87
2024
Q4 		$12.5M Buy
+53,900
New +$12.4M 0.3% 77
2024
Q3 		– Sell
-144,433
Closed -$28.4M – 101
2024
Q2 		$28.4M Hold
144,433
– – 0.67% 54
2024
Q1 		$31.1M Buy
144,433
+54,000
+60% +$11.3M 0.73% 53
2023
Q4 		$19M Buy
90,433
+70,433
+352% +$15M 0.46% 62
2023
Q3 		$4M Sell
20,000
-248,290
-93% -$49.4M 0.11% 85
2023
Q2 		$49.7M Hold
268,290
– – 1.2% 27
2023
Q1 		$51.4M Buy
+268,290
New +$48.5M 1.22% 25
2022
Q1 		– Sell
-120,000
Closed -$27.4M – 90
2021
Q4 		$27.4M Hold
120,000
– – 0.42% 67
2021
Q3 		$23.2M Sell
120,000
-62,000
-34% -$12.6M 0.39% 69
2021
Q2 		$38.7M Sell
182,000
-90,785
-33% -$19.2M 0.66% 57
2021
Q1 		$55.7M Buy
272,785
+174,785
+178% +$34.4M 1.08% 27
2020
Q4 		$17.8M Sell
98,000
-30,000
-23% -$5.1M 0.37% 78
2020
Q3 		$21.4M Sell
128,000
-9,821
-7% -$1.65M 0.56% 52
2020
Q2 		$22.4M Sell
137,821
-15,179
-10% -$2.72M 0.68% 48
2020
Q1 		$26.5M Buy
153,000
+50,000
+49% +$9.95M 0.97% 34
2019
Q4 		$20.7M Buy
103,000
+98,888
+2,405% +$20.3M 0.64% 40
2019
Q3 		$869K Buy
4,112
+1,141
+38% +$238K 0.02% 85
2019
Q2 		$577K Sell
2,971
-2,650
-47% -$489K 0.01% 91
2019
Q1 		$925K Buy
+5,621
New +$994K 0.02% 102

Other funds holding CME

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Capital World Investors
Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
Sanders Capital
Sanders Capital West Palm Beach, Florida $99.8B AUM 47.9% 1-Year Est. Return
Norges Bank
Norges Bank Oslo, Norway $1T AUM

Nan Shan Life Insurance's CME Position: Q2 2026 in Review

Nan Shan Life Insurance increased its CME Group (CME) stake by 95% in Q2 2026, buying an estimated $27M and bringing the position to 200,237 shares worth $44.2M. The position accounts for 1.39% of the portfolio, ranked #26.

Nan Shan Life Insurance first reported a position in CME in Q1 2019 and has held it in 24 quarters since. The position peaked at $55.7M in Q1 2021. 1,705 funds tracked by Wall St. Rank hold CME as of Q2 2026.

  • Nan Shan Life Insurance held 200,237 shares of CME Group worth $44.2M as of Q2 2026.
  • Nan Shan Life Insurance bought 97,697 CME Group shares in Q2 2026, an estimated $27M.
  • CME Group made up 1.39% of Nan Shan Life Insurance's portfolio in Q2 2026, its #26 holding.
  • Nan Shan Life Insurance first reported a position in CME Group in Q1 2019 and has held it in 24 quarters since.
  • Nan Shan Life Insurance's CME Group position peaked at $55.7M in Q1 2021.
  • 1,705 funds tracked by Wall St. Rank held CME Group as of Q2 2026.

Based on Nan Shan Life Insurance's 13F filing for Q2 2026, filed 14 Aug 2026.